Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,treasuryStock,otherAssets,cash,totalCurrentLiabilities,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,netReceivables,longTermDebt,inventory,accountsPayable,changeToLiabilities,totalCashflowsFromInvestingActivities,changeToOperatingActivities,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,changeToNetincome,capitalExpenditures,netBorrowings,totalCashFromFinancingActivities,otherCashflowsFromInvestingActivities,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,currency,esgPopulated,tradeable,market,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,marketState,shortName,exchange,epsTrailingTwelveMonths,exchangeDataDelayedBy,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,priceHint,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (Mar 10, 2003) 4","Short Ratio (Mar 10, 2003) 4","Short % of Float (Mar 10, 2003) 4","Short % of Shares Outstanding (Mar 10, 2003) 4","Shares Short (prior month Jan 09, 2003) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,fax,industry
t0,HMGN,-3556801,15500300,18120,,-162983,,-162983,427714,402129,-43705,-43705,,-120395,,,,0,875912,919617,473783,-119278,,-162983,-162983,23133611,5999545,-3556801,85938,2442744,156002,-26678231,-168183,65691,66287,1949687,-78547,282307,2094746,587521,4049858,1363052,368775,43966.0,-3564.0,6281.0,-41021.0,13381.0,-50838.0,36562.0,4836.0,-1775.0,22275.0,-3564.0,,,,145059,en-US,US,EQUITY,False,Delayed Quote,0.0,0.012495 - 0.012495,0.012495,0.0,0.0,0,0,finmb_324185,Other OTC,"Hemagen Diagnostics, Inc.",USD,3391,689,0.0054949997,0.7849999,0.007 - 0.052,-0.039505,-0.75971156,0.007,0.052,USD,False,False,us_market,0.012495,1630333123,0.0,0.012495,0.012495,0.012495,3218,PRE,HEMAGEN DIAGNOSTICS INC,PNK,-0.06,0,-0.229,0.013939166,-0.0014441665,-0.10360494,0.027873356,-0.015378356,-0.55172247,225296,-0.054563317,15,America/New_York,EDT,-14400000,4,0.01,,,0.052,0.007,0.0139,0.0279,3.39k,689,15.5M,,,0.00%,0.33%,,0,,0.00%,,,,,,,0.00%,,,,,"Sep 29, 2012","Sep 29, 2012",-22.45%,-10.83%,-10.27%,,4.04M,0.26,-23.60%,1.61M,-273.66k,-907.32k,-0.0600,,66.29k,0,5.03M,,1.07,-0.23,-358.69k,-115.85k,Value,21045,Healthcare,15,"Hemagen Diagnostics, Inc., a biotechnology company, provides human and veterinary clinical diagnostic solutions worldwide. The company develops, manufactures, and markets VIRGO, a human clinical diagnostic line of immunoassays for the diagnosis of autoimmune and infectious diseases, and acute phase proteins. Its human diagnostics products also comprise Universal IFA components; supplies, controls and calibrators, accessories, and H-rotors; reagents, electrodes, equipment; and specialty assays, including Chagas, acute phase proteins, and cytokines. In addition, the company provides veterinary diagnostic products, such as equipment, reagents, supplies, accessories, and electrodes in chemistry, hematology, and electrolyte areas. It sells its products directly, as well as through distributors to various laboratories, hospitals, and blood banks. The company was founded in 1985 and is based in Columbia, Maryland.",Columbia,443-367-5500,MD,1356912000,United States,http://www.hemagen.com,86400,9033 Red Branch Road,443-367-5527,Biotechnology
t-1,HMGN,-3434092,15500300,483,,-132132,,-132132,465275,453455,-12303,-12303,,-119813,,,,0,947807,960110,494352,-119829,,-132132,-132132,23109834,5955579,-3434092,29891,2521487,156002,-26515248,-184680,65140,107308,1905721,-95044,312190,2144157,585335,4049858,1366796,898962,34805.0,-15538.0,46248.0,20431.0,-63477.0,17016.0,40249.0,-548.0,-4283.0,32676.0,-15538.0,82430.0,82430.0,,238436,en-US,US,EQUITY,False,Delayed Quote,0.0,0.012495 - 0.012495,0.012495,0.0,0.0,0,0,finmb_324185,Other OTC,"Hemagen Diagnostics, Inc.",USD,3391,689,0.0054949997,0.7849999,0.007 - 0.052,-0.039505,-0.75971156,0.007,0.052,USD,False,False,us_market,0.012495,1630333123,0.0,0.012495,0.012495,0.012495,3218,PRE,HEMAGEN DIAGNOSTICS INC,PNK,-0.06,0,-0.229,0.013939166,-0.0014441665,-0.10360494,0.027873356,-0.015378356,-0.55172247,225296,-0.054563317,15,America/New_York,EDT,-14400000,4,0.01,,,0.052,0.007,0.0139,0.0279,3.39k,689,15.5M,,,0.00%,0.33%,,0,,0.00%,,,,,,,0.00%,,,,,"Sep 29, 2012","Sep 29, 2012",-22.45%,-10.83%,-10.27%,,4.04M,0.26,-23.60%,1.61M,-273.66k,-907.32k,-0.0600,,66.29k,0,5.03M,,1.07,-0.23,-358.69k,-115.85k,Value,21045,Healthcare,15,"Hemagen Diagnostics, Inc., a biotechnology company, provides human and veterinary clinical diagnostic solutions worldwide. The company develops, manufactures, and markets VIRGO, a human clinical diagnostic line of immunoassays for the diagnosis of autoimmune and infectious diseases, and acute phase proteins. Its human diagnostics products also comprise Universal IFA components; supplies, controls and calibrators, accessories, and H-rotors; reagents, electrodes, equipment; and specialty assays, including Chagas, acute phase proteins, and cytokines. In addition, the company provides veterinary diagnostic products, such as equipment, reagents, supplies, accessories, and electrodes in chemistry, hematology, and electrolyte areas. It sells its products directly, as well as through distributors to various laboratories, hospitals, and blood banks. The company was founded in 1985 and is based in Columbia, Maryland.",Columbia,443-367-5500,MD,1356912000,United States,http://www.hemagen.com,86400,9033 Red Branch Road,443-367-5527,Biotechnology
t-2,HMGN,-3244671,15500300,25305,,-243642,,-243642,452424,350530,-127199,-127199,,-115077,,,,0,1111301,1238500,760771,-116443,,-243642,-243642,23085867,5838344,-3244671,36860,2593673,155952,-26383117,-103373,78081,86877,1788486,-13737,354730,2160862,589712,4049858,1366248,857188,35122.0,-7238.0,-7155.0,68014.0,16917.0,-116678.0,43921.0,199612.0,-161681.0,17145.0,-7238.0,175013.0,175013.0,,372376,en-US,US,EQUITY,False,Delayed Quote,0.0,0.012495 - 0.012495,0.012495,0.0,0.0,0,0,finmb_324185,Other OTC,"Hemagen Diagnostics, Inc.",USD,3391,689,0.0054949997,0.7849999,0.007 - 0.052,-0.039505,-0.75971156,0.007,0.052,USD,False,False,us_market,0.012495,1630333123,0.0,0.012495,0.012495,0.012495,3218,PRE,HEMAGEN DIAGNOSTICS INC,PNK,-0.06,0,-0.229,0.013939166,-0.0014441665,-0.10360494,0.027873356,-0.015378356,-0.55172247,225296,-0.054563317,15,America/New_York,EDT,-14400000,4,0.01,,,0.052,0.007,0.0139,0.0279,3.39k,689,15.5M,,,0.00%,0.33%,,0,,0.00%,,,,,,,0.00%,,,,,"Sep 29, 2012","Sep 29, 2012",-22.45%,-10.83%,-10.27%,,4.04M,0.26,-23.60%,1.61M,-273.66k,-907.32k,-0.0600,,66.29k,0,5.03M,,1.07,-0.23,-358.69k,-115.85k,Value,21045,Healthcare,15,"Hemagen Diagnostics, Inc., a biotechnology company, provides human and veterinary clinical diagnostic solutions worldwide. The company develops, manufactures, and markets VIRGO, a human clinical diagnostic line of immunoassays for the diagnosis of autoimmune and infectious diseases, and acute phase proteins. Its human diagnostics products also comprise Universal IFA components; supplies, controls and calibrators, accessories, and H-rotors; reagents, electrodes, equipment; and specialty assays, including Chagas, acute phase proteins, and cytokines. In addition, the company provides veterinary diagnostic products, such as equipment, reagents, supplies, accessories, and electrodes in chemistry, hematology, and electrolyte areas. It sells its products directly, as well as through distributors to various laboratories, hospitals, and blood banks. The company was founded in 1985 and is based in Columbia, Maryland.",Columbia,443-367-5500,MD,1356912000,United States,http://www.hemagen.com,86400,9033 Red Branch Road,443-367-5527,Biotechnology
t-3,HMGN,-3041599,15500300,740,,-368559,,-368559,661298,407331,-254707,-254707,,-113889,,,,0,1107074,1361781,699743,-113852,,-368559,-368559,23062257,5628209,-3041599,32213,2586610,155902,-26139475,-120283,55811,18863,1578351,-30647,391420,2139379,419163,4049858,1568213,826712,2825.0,-29697.0,23200.0,-194748.0,-6876.0,-208187.0,43518.0,-94338.0,160670.0,24497.0,-64697.0,50012.0,50012.0,35000.0,561028,en-US,US,EQUITY,False,Delayed Quote,0.0,0.012495 - 0.012495,0.012495,0.0,0.0,0,0,finmb_324185,Other OTC,"Hemagen Diagnostics, Inc.",USD,3391,689,0.0054949997,0.7849999,0.007 - 0.052,-0.039505,-0.75971156,0.007,0.052,USD,False,False,us_market,0.012495,1630333123,0.0,0.012495,0.012495,0.012495,3218,PRE,HEMAGEN DIAGNOSTICS INC,PNK,-0.06,0,-0.229,0.013939166,-0.0014441665,-0.10360494,0.027873356,-0.015378356,-0.55172247,225296,-0.054563317,15,America/New_York,EDT,-14400000,4,0.01,,,0.052,0.007,0.0139,0.0279,3.39k,689,15.5M,,,0.00%,0.33%,,0,,0.00%,,,,,,,0.00%,,,,,"Sep 29, 2012","Sep 29, 2012",-22.45%,-10.83%,-10.27%,,4.04M,0.26,-23.60%,1.61M,-273.66k,-907.32k,-0.0600,,66.29k,0,5.03M,,1.07,-0.23,-358.69k,-115.85k,Value,21045,Healthcare,15,"Hemagen Diagnostics, Inc., a biotechnology company, provides human and veterinary clinical diagnostic solutions worldwide. The company develops, manufactures, and markets VIRGO, a human clinical diagnostic line of immunoassays for the diagnosis of autoimmune and infectious diseases, and acute phase proteins. Its human diagnostics products also comprise Universal IFA components; supplies, controls and calibrators, accessories, and H-rotors; reagents, electrodes, equipment; and specialty assays, including Chagas, acute phase proteins, and cytokines. In addition, the company provides veterinary diagnostic products, such as equipment, reagents, supplies, accessories, and electrodes in chemistry, hematology, and electrolyte areas. It sells its products directly, as well as through distributors to various laboratories, hospitals, and blood banks. The company was founded in 1985 and is based in Columbia, Maryland.",Columbia,443-367-5500,MD,1356912000,United States,http://www.hemagen.com,86400,9033 Red Branch Road,443-367-5527,Biotechnology
